Patients treated with high-dose BIIB080 saw positive trends on the global Clinical Dementia Rating Sum of Boxes, Mini-Mental State Exam cognitive scales and Functional Activities Questionnaire at week ...
Case Western Reserve University and Ionis Pharmaceuticals Inc. have signed an exclusive license agreement to advance and commercialize a therapeutic approach discovered by university medical ...
Scientists at St. Jude Children's Research Hospital have found that they can reverse the effects of HNRNPH2-related ...
Hoth Therapeutics Inc. (NASDAQ:HOTH) on Tuesday announced combined findings from multiple preclinical programs evaluating its precision antisense candidate HT-KIT. HT-KIT is a precision antisense ...
An experimental drug designed to silence a gene strongly linked to Parkinson's disease has shown encouraging effects in a first-in-human clinical trial, according to a study published in Nature ...
Morning Overview on MSN
Early trial: BIIB094 cuts Parkinson’s-linked LRRK2 protein up to 60%
For the roughly one million Americans living with Parkinson’s disease, every approved treatment does the same thing: manage symptoms. None slows the underlying brain degeneration. Results published in ...
BioWorld - Monday, April 6, 2026 Breaking News: Best of BioWorld Science: Q1 See today's BioWorld Science Home » Antisense oligonucleotide targeting nicotinamide N-methyltransferase as a potential ...
Biogen has agreed to acquire Apellis Pharmaceuticals after an extended negotiation process. The company also entered a collaboration with Alloy Therapeutics focused on antisense drug development using ...
Scientists at St. Jude Children's Research Hospital have found they can reverse the effects of HNRNPH2-related ...
“Together, these findings support a beneficial role for CD47 knockdown in alleviating age-associated metabolic dysfunction through coordinated effects across multiple organs” “Together, these findings ...
HT-KIT triggered significant tumor cell death in preclinical models of gastrointestinal stromal tumors (GIST) and systemic mastocytosis as early as 24 hours post-treatment, with statistically ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results